The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium
Open accessAbstract
Background/Objectives Induced pluripotent stem cells (iPS) exhibit enhanced survival and proliferation in ischemic tissues. However, the therapeutic application of iPS cells is limited by their tumorigenic potential. We hypothesized that iPS cells can transmit cytoprotective signals to cardiomyocytes via exosomes/microvesicles. Methods Exosomes/microvesicles secreted from mouse cardiac fibroblast (CF)-derived iPS cells (iPS-exo) were purified from conditioned medium and confirmed by electron micrograph, size distribution and zeta potential by particle tracking analyzer and protein expression of the exosome markers CD63 and Tsg101. Results We observed that exosomes are at low zeta potential, and easily aggregate. Temperature affects zeta potential (−14~−15mV at 23°C vs −24mV at 37°C). The uptake of iPS-exo protects H9C2 cells against H2O2-induced oxidative stress by inhibiting caspase 3/7 activation (P<0.05, n=6). Importantly, iPS-exo treatment can protect against myocardial ischemia/reperfusion (MIR) injury via intramyocardially injection into mouse ischemic myocardium before reperfusion. Furthermore, iPS-exo deliver cardioprotective miRNAs, including nanog-regulated miR-21 and HIF-1α-regulated miR-210, to H9C2 cardiomyocytes in vitro. Conclusions exosomes/microvesicles secreted by iPS cells are very effective at transmitting cytoprotective signals to cardiomyocytes in the setting of MIR. iPS-exo thus represent novel biological nanoparticles that offer the benefits of iPS cell therapy without the risk of tumorigenicity and can potentially serve as an “ off-the-shelf” therapy to rescue ischemic cardiomyocytes in conditions such as MIR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., et al. (1995) · Nature · doi:10.1038/376037a0 · Cited by 3,979
Jia, Q.-W., Chen, Z.-H., Ding, X.-Q., Liu, J.-Y., Ge, P.-C., An, F.-H., Li, L.-H., Wang, L.-S., Ma, W.-Z., Yang, Z.-J., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000478071 · Cited by 1,691
Circulating MicroRNAs: Novel Biomarkers and Extracellular Communicators in Cardiovascular Disease?
Creemers, E. E., Tijsen, A. J., & Pinto, Y. M. (2012) · Circulation Research · doi:10.1161/circresaha.111.247452 · Cited by 1,009
Sequential Expression of Pluripotency Markers during Direct Reprogramming of Mouse Somatic Cells
Brambrink, T., Foreman, R., Welstead, G. G., Lengner, C. J., Wernig, M., Suh, H., & Jaenisch, R. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.01.004 · Cited by 821
Lee, C., Mitsialis, S. A., Aslam, M., Vitali, S. H., Vergadi, E., Konstantinou, G., Sdrimas, K., Fernandez-Gonzalez, A., & Kourembanas, S. (2012) · Circulation · doi:10.1161/circulationaha.112.114173 · Cited by 793
Zhang, J., Guan, J., Niu, X., Hu, G., Guo, S., Li, Q., Xie, Z., Zhang, C., & Wang, Y. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0417-0 · Cited by 778
Self-citationTumorigenicity as a clinical hurdle for pluripotent stem cell therapies
Lee, A. S., Tang, C., Rao, M. S., Weissman, I. L., & Wu, J. C. (2013) · Nature Medicine · doi:10.1038/nm.3267 · Cited by 727
Reprogramming in vivo produces teratomas and iPS cells with totipotency features
Abad, M., Mosteiro, L., Pantoja, C., Cañamero, M., Rayon, T., Ors, I., Graña, O., Megías, D., Domínguez, O., Martínez, D., et al. (2013) · Nature · doi:10.1038/nature12586 · Cited by 547
Narazaki, G., Uosaki, H., Teranishi, M., Okita, K., Kim, B., Matsuoka, S., Yamanaka, S., & Yamashita, J. K. (2008) · Circulation · doi:10.1161/circulationaha.108.769562 · Cited by 476
Won Kim, H., Haider, H. K., Jiang, S., & Ashraf, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.020925 · Cited by 370
Tang, Y. L., Zhu, W., Cheng, M., Chen, L., Zhang, J., Sun, T., Kishore, R., Phillips, M. I., Losordo, D. W., & Qin, G. (2009) · Circulation Research · doi:10.1161/circresaha.109.197723 · Cited by 363
Self-citationChen, L., Wang, Y., Pan, Y., Zhang, L., Shen, C., Qin, G., Ashraf, M., Weintraub, N., Ma, G., & Tang, Y. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.015 · Cited by 359
Self-citationMicroRNAs and Cell Cycle Regulation
Carleton, M., Cleary, M. A., & Linsley, P. S. (2007) · Cell Cycle · doi:10.4161/cc.6.17.4641 · Cited by 343
Sayed, D., He, M., Hong, C., Gao, S., Rane, S., Yang, Z., & Abdellatif, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.109207 · Cited by 315
Lipid-based carriers of microRNAs and intercellular communication
Vickers, K. C., & Remaley, A. T. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328350a425 · Cited by 314
Ostolska, I., & Wiśniewska, M. (2014) · Colloid and Polymer Science · doi:10.1007/s00396-014-3276-y · Cited by 275
Bourguignon, L. Y. W., Earle, C., Wong, G., Spevak, C. C., & Krueger, K. (2012) · Oncogene · doi:10.1038/onc.2011.222 · Cited by 239 · cited 2×
“miR-21 and miR −210 are two major cardioprotective miRNAs which are regulated by Nanog [14] and hypoxia-inducible factor-1 α (HIF-1α) [15], respectively, and have been reported to protect”
BackgroundHu, G., Yao, H., Chaudhuri, A. D., Duan, M., Yelamanchili, S. V., Wen, H., Cheney, P. D., Fox, H. S., & Buch, S. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.114 · Cited by 204
Pulkkinen, K., Malm, T., Turunen, M., Koistinaho, J., & Ylä-Herttuala, S. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.05.048 · Cited by 187
Cardiomyocyte death and renewal in the normal and diseased heart
Buja, L. M., & Vela, D. C. (2008) · Cardiovascular Pathology · doi:10.1016/j.carpath.2008.02.004 · Cited by 175
Functional transfer of microRNA by exosomes
Stoorvogel, W. (2012) · Blood · doi:10.1182/blood-2011-11-389478 · Cited by 174
Mutharasan, R. K., Nagpal, V., Ichikawa, Y., & Ardehali, H. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01080.2010 · Cited by 174
Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers
Jo, W., Jeong, D., Kim, J., Cho, S., Jang, S. C., Han, C., Kang, J. Y., Gho, Y. S., & Park, J. (2014) · Lab Chip · doi:10.1039/c3lc50993a · Cited by 167
Marimpietri, D., Petretto, A., Raffaghello, L., Pezzolo, A., Gagliani, C., Tacchetti, C., Mauri, P., Melioli, G., & Pistoia, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075054 · Cited by 158
Generation and Characterization of Human Induced Pluripotent Stem Cells
Ohnuki, M., Takahashi, K., & Yamanaka, S. (2009) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc04a02s9 · Cited by 137
Mesenchymal Stem Cell Exosome Ameliorates Reperfusion Injury Through Proteomic Complementation
Lai, R. C., Yeo, R. W. Y., Tan, K. H., & Lim, S. K. (2013) · Regenerative Medicine · doi:10.2217/rme.13.4 · Cited by 134
Syndecan-4 Prevents Cardiac Rupture and Dysfunction After Myocardial Infarction
Matsui, Y., Ikesue, M., Danzaki, K., Morimoto, J. O., Sato, M., Tanaka, S., Kojima, T., Tsutsui, H., & Uede, T. (2011) · Circulation Research · doi:10.1161/circresaha.110.235689 · Cited by 116
Quantification and Size-profiling of Extracellular Vesicles Using Tunable Resistive Pulse Sensing
Maas, S. L. N., de Vrij, J., & Broekman, M. L. D. (2014) · Journal of Visualized Experiments · doi:10.3791/51623 · Cited by 108
The tumourigenicity of iPS cells and their differentiated derivates
Liu, Z., Tang, Y., Lü, S., Zhou, J., Du, Z., Duan, C., Li, Z., & Wang, C. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12062 · Cited by 102
Self-citationLee, P. Y., Chien, Y., Chiou, G., Lin, C., Chiou, C.-H., & Tarng, D. (2012) · Cell Transplantation · doi:10.3727/096368912x636902 · Cited by 101
Hypoxia and pluripotency in embryonic and embryonal carcinoma stem cell biology
Silván, U., Díez-Torre, A., Arluzea, J., Andrade, R., Silió, M., & Aréchaga, J. (2009) · Differentiation · doi:10.1016/j.diff.2009.06.002 · Cited by 93
Forristal, C. E., Christensen, D. R., Chinnery, F., Petruzzelli, R., Parry, K. L., Sánchez-Elsner, T., & Houghton, F. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062507 · Cited by 89
Effective Cardiac Myocyte Differentiation of Human Induced Pluripotent Stem Cells Requires VEGF
Ye, L., Zhang, S., Greder, L. V., Dutton, J. R., Keirstead, S. A., Lepley, M., Zhang, L., Kaufman, D. S., & Zhang, J. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053764 · Cited by 75
Self-citationAnsa-Addo, E. A., Lange, S., Stratton, D., Antwi-Baffour, S. S., Cestari, I. D. S., Ramirez, M. I., McCrossan, M. V., & Inal, J. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001656 · Cited by 67
Cardiac-derived stem cell-based therapy for heart failure: progress and clinical applications
Tang, Y., Wang, Y. J., Chen, L. J., Pan, Y., Zhang, L., & Weintraub, N. L. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213477982 · Cited by 43
Self-citationZhang, L., Pan, Y., Qin, G., Chen, L., Chatterjee, T., Weintraub, N. L., & Tang, Y. (2014) · Cell Cycle · doi:10.4161/cc.27677 · Cited by 36
Self-citationQuantification and Size-profiling of Extracellular Vesicles Using Tunable Resistive Pulse Sensing
Maas, S. L. N., de Vrij, J., & Broekman, M. L. D. (2014) · Journal of Visualized Experiments · doi:10.3791/51623-v · Cited by 31
Cited by
Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper
Lener, T., Gimona, M., Aigner, L., Börger, V., Buzas, E., Camussi, G., Chaput, N., Chatterjee, D., Court, F. A., del Portillo, H. A., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.30087 · Cited by 1,491
Gurunathan, S., Kang, M.-H., Jeyaraj, M., Qasim, M., & Kim, J.-H. (2019) · Cells · doi:10.3390/cells8040307 · Cited by 1,122
Advances in therapeutic applications of extracellular vesicles
Wiklander, O. P. B., Brennan, M. Á., Lötvall, J., Breakefield, X. O., & EL Andaloussi, S. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav8521 · Cited by 1,039
Helwa, I., Cai, J., Drewry, M. D., Zimmerman, A., Dinkins, M. B., Khaled, M. L., Seremwe, M., Dismuke, W. M., Bieberich, E., Stamer, W. D., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170628 · Cited by 612
Self-citationNative and bioengineered extracellular vesicles for cardiovascular therapeutics
de Abreu, R. C., Fernandes, H., da Costa Martins, P. A., Sahoo, S., Emanueli, C., & Ferreira, L. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0389-5 · Cited by 493
Metadata
- Authors
- Wang, Y., Zhang, L., Li, Y., Chen, L., Wang, X., Guo, W., Zhang, X., Qin, G., He, S.-H., Zimmerman, A., Liu, Y., Kim, I.-M., Weintraub, N. L., & Tang, Y.
- Venue
- International Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 192
- Pages
- 61-69
- ISSN
- 0167-5273 (ISSN-L)
- OpenAlex
- W1808455042
- Cited by
- 439
- References
- 39
- FWCI
- 15.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.